hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

HC rejects Bayer’s plea [India]

Author: Rupali Mukherjee, Times of India , Published on: 19 August 2009

Promoting consumers access to affordable medicines, the Delhi High Court...rejected pharma MNC Bayer's petition, which had indirectly sought ‘patent linkage'... patent linkages mean that no marketing approval is given for generic versions of medicines, which have been granted a patent in India...While holding that unpatented drugs are not spurious drugs, Justice Ravindra Bhat held that this petition was an attempt to tweak public policy. [refers to Cipla]

Read the full post here

Related companies: Bayer Cipla